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Fibroblast growth factor-1 (FGF-1) is abundantly present in the lung and has mitogenic and
neurotrophic activities similarly to neurotrophins. In order to determine whether FGF-1
associates with neurotrophins in alveolar macrophages, we investigated the immuno-
cytochemical colocalization of FGF-1 with neurotrophins, nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3), in mouse alveolar
macrophages. The results showed that 34% of macrophages were immunoreactive for
FGF-1, 10% for NGF, 9% for BDNF, and 17% for NT-3. Of FGF-1-immunoreactive (IR)
macrophages, 16% were immunoreactive for NT-3, but only small percentages were
immunoreactive for NGF (0.8%) and for BDNF (0.3%). FGF-1 and neurotrophins were all
localized in the intracellular vesicles. In the vesicles, FGF-1 and NT-3 were frequently
colocalized. All macrophages expressed lysosome-associated protein-2 (LAMP-2), a late
endosomal and lysosomal marker, and early endosomes antigen 1 (EEA1), an early
endosomal marker. FGF-1 and NT-3 were predominantly colocalized with LAMP-2 rather
than with EEA1, whereas NGF and BDNF were colocalized with EEA1 rather than with
LAMP-2. These results indicate that FGF-1 and NT-3 are substantially expressed in mouse
alveolar macrophages and colocalized in vesicles, predominantly in late endosomes and
lysosomes.
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I. Introduction
Macrophages are a major cellular component of the
lung. They provide local defense against a variety of
pathogenic particulates passing through the airway and play
a role in airway inflammation. Macrophages ingest foreign
substances in a phagocytic manner and release chemical
factors, such as interleukin-1 (IL-1) and tumor necrosis
factor-α (TNF-α), in response to inflammatory stimuli [10,
14]. Besides these classical inflammatory chemicals, alve-
olar macrophages have been recently known to express
growth factors and neurotrophins [6, 14, 20].
Fibroblast growth factor-1 (FGF-1) is highly expressed
in the normal human lung [8] including alveolar macro-
phages as well as bronchial epithelium [12]. This growth
factor is likely to have a cell proliferation effect on various
types of cells in the lung. Treatment with FGF-1 has been
shown to promote proliferation of human airway smooth
muscle cells [12], rat alveolar type II cells [15], rodent lung
epithelial cells [3, 5], mouse fibroblast cell lines [11, 22],
and rabbit ligament fibroblasts [21]. Besides these mitogenic
effects, FGF-1 has been found to exhibit neurotrophic
activity, such as the promotion of neurite outgrowth in
cultured rat sensory neurons [16], the survival and regener-
ation of neurons in the rat vagal preganglion nerve afterHiruma et al. 132
injury [9], and the recovery of sensory function after
transsection of cervical roots in rats [7]. Thus, FGF-1 is
likely a regulator of the structure modeling in the lung via
cell proliferation of various lung cells and maintenance of
neurons.
Alveolar macrophages also express the neurotrophin
family, which comprises nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), neurotrophin-3 (NT-
3), and neurotrophin-4/5 (NT-4/5). Ricci et al. [20] showed
immunocytochemical expression of NGF and neurotrophin
receptors TrkA, TrkB, and TrkC in alveolar macrophages
obtained from bronchoalveolar lavage (BAL) fluid of normal
human subjects. They therefore suggest that macrophage-
derived NGF acts on macrophages in an autocrine or
paracrine manner and regulates their functions including
phagocytosis, IL-1 production, and macrophage differenti-
ation. We have also previously shown that mRNAs for NT-
3 and NT-4/5 are expressed in alveolar macrophages of
intact mice and their receptors TrkB and TrkC are located
in interstitial macrophages, suggesting the presence of the
signal communication via neurotrophins in the peripheral
lung [6]. Physiologically, the neurotrophins in the lung,
whose sources are sensory neurons (non-adrenergic and
non-cholinergic neurons), epithelial cells, fibroblasts, and
immune cells including macrophages, are possibly required
for differentiation and maintenance of peripheral sensory
neurons [17]. Recently, more information on the physiolog-
ical action of neurotrophins in the lung has been described.
The neurotrophins play roles in the normal lung development
and lung health at least in part through the cell proliferation
of airway smooth muscle cells, pulmonary endothelial cells,
and epithelial cells [18].
Thus, FGF-1 and neurotrophins are expressed in
alveolar macrophages and have overlapping actions, such
as mitogenic and neurotrophic actions. Therefore, FGF-1 in
alveolar macrophages might associate with neurotrophins in
various processes such as storage, release, and action upon
the target. Knowledge of their intracellular storage will help
us to understand the capacity and manner of their release.
Accordingly, we investigated the intracellular colocalization
of FGF-1 with neurotrophins, NGF, BDNF, and NT-3, in
mouse alveolar macrophages. We further investigated the
intracellular colocalization of these factors with lysosome-
associated protein-2 (LAMP-2), a late endosomal and
lysosomal marker, and with early endosome antigen 1
(EEA1), an early endosomal marker, to determine their
precise intracellular localization.
II. Materials and Methods
Animals
Animal care was in accordance with the guidelines of
the Animal Care Committee of Kitasato University School
of Medicine. C57BL/6 male mice, 12–20 weeks of age, were
deeply anesthetized and euthanized with diethyl ether, and
BAL fluid was obtained as described below. A total of 30
mice were used in this study.
Preparation of alveolar macrophages
The trachea was cannulated with a nylon tube, and the
lung was lavaged five times with 1 ml Earle’s balanced
salt solution (Life Technologies, Carlsbad, CA, USA) for
collecting alveolar macrophages. The BAL fluid specimens
were centrifuged at 300 g for 5 min. The pelleted cells were
suspended in Roswell Park Memorial Institute (RPMI) 1640
medium (Life Technologies). Cells were plated on coverslips
in dishes and incubated at 37°C for 90 min in an atmosphere
of 5% CO2-95% air, in an attempt to purify the adherent
cells as macrophages. After incubation, non-adherent cells
were removed by swirling the dish to resuspend these cells
and aspirating them off with a Pasteur pipette. The dish was
then sprayed with medium by using a pipette to resuspend
loosely adherent cells. The suspension was aspirated off
again, and the adherent macrophages were used for prepa-
ration of immunocytochemistry. The purity of macrophages
was 99.6±0.3% (Mean±SEM, N=23 microscopic fields, total
638 cells) as determined by morphological analysis com-
bined with toluidine blue (0.1% in PBS) staining. The
remaining 0.4% were fibroblasts. There were no mast cells
whose cytoplasmic granules are stained red-violet by
toluidine blue.
Immunocytochemical procedure
Alveolar macrophages were fixed with 4% paraform-
aldehyde for 5 min at room temperature. After fixation, they
were washed with 0.025 M phosphate-buffered saline (PBS)
containing 0.3% Triton X-100 (PBST) for 10 min, and
treated for 10 min with protein blocking agent (Immunon,
Pittsburgh, PA, USA) at room temperature to block
nonspecific protein sites. Cells were incubated for 1 hr at
room temperature with the primary antibody, goat anti-
human FGF-1 antibody (4 μg/ml, reacts with mouse, rat,
and human FGF-1, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), rabbit anti-mouse NGF antibody (1:500, Serotec,
Oxford, UK), chicken anti-mouse NGF antibody (2 μg/ml,
Chemicon International, Temecula, CA, USA), rabbit anti-
mouse BDNF antibody (1:1000, Chemicon International),
chicken anti-human BDNF antibody (2 μg/ml, reacts with
human and mouse BDNF, General Laboratories, Madison,
WI, USA), sheep anti-mouse NT-3 antibody (10 μg/ml,
Chemicon International), or chicken anti-human NT-3
antibody (1:100, reacts with human and mouse NT-3,
Abcam, Tokyo). For each of NGF, BDNF, and NT-3, we
used two antibodies derived from different species indicated
above, and there was virtually no difference in the results
between them. Rat monoclonal anti-mouse LAMP-2 anti-
body (1:100, Santa Cruz Biotechnology) and rabbit anti-
human EEA1 antibody (1:100, reacts with mouse, rat, and
human EEA1, Sigma-Aldrich, St. Louis, MO, USA) were
also used. Double labeling was performed using two primary
antibodies derived from different species. After washing
with PBS, the macrophages were incubated for 1 hr at room
temperature with the secondary antibodies, Alexa Fluor 568
IgG (1:100, Life Technologies) and Alexa Fluor 488 IgG
(1:100, Life Technologies), corresponding to the primaryFGF-1 and NT-3 in Alveolar Macrophages 133
antibodies. No staining was observed with isotype-matched
negative controls (goat IgG, rabbit IgG, sheep IgG, chicken
IgY, and rat IgG2a). The secondary antibodies without the
primary antibody did not stain alveolar macrophages. The
immunostained cells on coverslips were usually examined
with an inverted microscope (Axiovert 135 TV Carl Zeiss,
Oberkochen, Germany) equipped with excitation filters (546
nm for Alexa Fluor 568, 450–490 nm for Alexa Fluor 488)
and emission filters (590 nm for Alexa Fluor 568, 515–565
nm for Alexa Fluor 488). The photomicrographs were taken
by digital camera (AxioCam MRm, Carl Zeiss) driven by
AxioVision 4.7 software (Carl Zeiss).
Confocal microscopic observation
Intracellular localization of FGF-1, NGF, BDNF, NT-
3, LAMP-2, and EEA1 was investigated under a Zeiss
LSM510 confocal microscope equipped with argon (488
nm) and helium-neon (543 nm) lasers to excite green and
red fluorescence, respectively. A 100×/1.4 oil immersion
objective was used.
Analysis
The number of macrophages immunoreactive for each
of FGF-1 and neurotrophins was counted in the microscopic
field, and the percentage of immunoreactive cells to total
cells in the field was calculated. One to 3 fields were
examined for each coverslip. The mean±SEM percentage
was then calculated from all microscopic fields examined.
The degree of colocalization of FGF-1 with neurotrophins
at the cellular level was expressed as the mean (±SEM)
percentage of double-labeled cells to total FGF-1-IR cells
in the microscopic field. Colocalization in intracellular
vesicles (colocalization of FGF-1 with NT-3 and colocal-
ization of FGF-1, NGF, BDNF, or NT-3 with LAMP-2 or
EEA1) was also analyzed. The mean (±SEM) percentage
of double-labeled vesicles to vesicles immunoreactive for
each of FGF-1 and neurotrophins in the cell were calculated.
Significance of difference was determined by repeated
measures analysis of variance (ANOVA) followed by the
Bonferroni-Dunn post hoc test. Statistical significance was
determined as P<0.05.
III. Results
Immunocytochemical expression of FGF-1 and 
neurotrophins in mouse alveolar macrophages
Immunocytochemistry revealed that some alveolar
macrophages were stained with antibodies against FGF-1,
NGF, BDNF, or NT-3 (Fig. 1A). Mean percentages of the
immunoreactive  alveolar  macrophages  to  total  macro-
phages were 34% for FGF-1, 10% for NGF, 9% for BDNF,
and 17% for NT-3 (Fig. 1B). The percentage of FGF-1-
immunoreactive (IR) macrophages and that of NT-3-IR
macrophages were significantly higher than that of NGF-IR
macrophages or of BDNF-IR macrophages (Fig. 1B).
Immunoreactivities for FGF-1, NGF, BDNF, and NT-3 were
all located in intracellular vesicles (Figs. 2A, 3A, and 4A).
Cellular colocalization of FGF-1 with neurotrophins
Double labeling with FGF-1 and one of the neuro-
trophin family members showed that some FGF-1-IR
macrophages were immunoreactive for NT-3 (Fig. 1A,
upper panels) and almost no FGF-1-IR macrophages were
immunoreactive for NGF or BDNF (Fig. 1A, middle and
lower panels). The quantitative analysis indicated that 16%
of FGF-1-IR macrophages were immunoreactive for NT-3,
whereas only small percentages of FGF-1-IR macrophages
were immunoreactive for NGF (0.8%) and for BDNF
(0.3%) (Fig. 1C). The ratio (percentage) of colocalization
of FGF-1 with NT-3 was significantly higher than that with
NGF and with BDNF (Fig. 1C).
Vesicular colocalization of FGF-1 with NT-3
In macrophages double-labeled with FGF-1 and NT-3,
some intracellular vesicles were observed to be immuno-
reactive for both (Fig. 2A). Results of quantitative analysis
for colocalization at the vesicular level are shown in
Figure 2B. The majority (89%) of FGF-1-IR vesicles were
immunoreactive for NT-3, and reversely, 64% of NT-3-IR
vesicles were immunoreactive for FGF-1. Since FGF-1 was
rarely colocalized with NGF or BDNF at cellular level as
described above, quantitative analysis of vesicular colo-
calization of FGF-1 with these two neurotrophins could
not be determined.
Vesicular colocalization with LAMP-2 and EEA1
We further investigated the precise intracellular local-
ization of FGF-1 and neurotrophins using antibodies against
LAMP-2, a late endosomal and lysosomal marker and
against EEA1, an early endosomal marker. All alveolar
macrophages had immunoreactivity for LAMP-2 and for
EEA1, and the immunoreactivities for LAMP-2 and EEA1
were located in intracellular vesicles.
As shown in Figure 3A, some of the FGF-1-IR,
NGF-IR, BDNF-IR, and NT-3-IR vesicles were immuno-
reactive for LAMP-2. Quantitative analysis showed that
two-thirds of FGF-1-IR (65%) and of NT-3-IR (66%)
vesicles were immunoreactive for LAMP-2, and one-third
of NGF-IR (33%) and of BDNF-IR (37%) vesicles had
immunoreactivity for LAMP-2 (Fig. 3B). The ratio of
colocalization of FGF-1 with LAMP-2 and that of NT-3
with LAMP-2 were significantly higher than that of NGF
with LAMP-2 or of BDNF with LAMP-2 (Fig. 3B).
Vesicular colocalization with EEA1 was also observed
(Fig. 4A), but its degree was different from that with
LAMP-2 (Fig. 4B). One-third of FGF-1-IR vesicles (30%)
and of NT-3-IR vesicles (34%) were immunoreactive
for EEA1, and a half of NGF-IR vesicles (53%) and of
BDNF-IR vesicles (48%) were immunoreactive for EEA1
(Fig. 4B). The percentage of colocalization of FGF-1 with
EEA1 and that of NT-3 with EEA1 were significantly lower
than that of NGF with EEA1 or that of BDNF with EEA1
(Fig. 4B).Hiruma et al. 134
Fig. 1. Expression and colocalization of FGF-1 with neurotrophins in mouse alveolar macrophages. (A) Double immunocytochemical staining
of macrophages with FGF-1 and NGF (upper panels), with FGF-1 and BDNF (middle panel), and with FGF-1 and NT-3 (lower panels). Panels
in the first column show differential interference contrast (DIC) images. Panels in the fourth column represent merged images of the second and
third columns. Bars=10 μm. (B) Expression ratio of FGF-1, NGF, BDNF, and NT-3 in alveolar macrophages. Mean percentages of the number
of macrophages immunoreactive for FGF-1, NGF, BDNF, and NT-3 to the number of total macrophages are shown. (C) Ratio of colocalization
of FGF-1 with neurotrophins in alveolar macrophages. The percentages of double-immunoreactive macrophages to FGF-1-immunoreactive
macrophages are shown. (B, C) Error bars represent standard error of the mean. (+), the presence of immunoreactivity; Mφ, macrophages; N,
number of microscopic fields examined (total cell numbers are indicated below); P, probability of significance.FGF-1 and NT-3 in Alveolar Macrophages 135
IV. Discussion
The present immunocytochemical study indicated that
mouse alveolar macrophages express FGF-1 and neuro-
trophins, NGF, BDNF, and NT-3, in their vesicles.
The previous immunohistochemical study on the
normal human lung tissue demonstrated that FGF-1 is
constitutively expressed in alveolar macrophages [12],
though its quantitative analysis has not been performed.
In the present study, we analyzed the number of immuno-
reactive alveolar macrophages and obtained the result that
34% of macrophages expressed FGF-1. This indicates that
mouse alveolar macrophages store a substantial amount of
FGF-1.
Mouse alveolar macrophages also appear to contain
high amounts of NT-3. The present result showed that 17%
of macrophages were immunoreactive for NT-3 and this
was higher than the ratio of NGF-expressing macrophages
(10%) or of BDNF-expressing macrophages (9%). These
results are somewhat different from those obtained from
normal human alveolar macrophages. Ricci et al. [20] have
shown that 2.5% of normal human alveolar macrophages
were immunoreactive for NGF and that no macrophages
were immunoreactive for BDNF or NT-3. The difference
between their results and ours might depend on the species
observed. Indeed, the species differences in the localization
of neurotrophins have been found. For example, NGF is
immunohistochemically detected in salivary glands in mice
but not in humans [4]. Enzyme-linked immunoassay detects
BDNF in human and rat but not mouse serum [19]. If the
localization differences are attributed to species specificity,
the data from mice may not be applicable to humans.
Fig. 2. Colocalization of FGF-1 and NT-3 in vesicles of mouse
alveolar macrophages. (A) Confocal images showing colocalization
of FGF-1 and NT-3 in the vesicles. The first panel shows DIC
image and the fourth panel shows a merged image of the second
and third panels. Bars=5 μm. (B) Ratio of colocalization of FGF-1
and NT-3 in vesicles of alveolar macrophages. The 36 cells
immunoreactive for both FGF-1 and NT-3 were examined. (+),
the presence of immunoreactivity; (–), the absence of immuno-
reactivity.
Fig. 3. Colocalization of FGF-1, NGF, BDNF, and NT-3 with
LAMP-2 in vesicles of mouse alveolar macrophages. (A) Confocal
images showing colocalization of FGF-1, NGF, BDNF, and NT-3
with LAMP-2, a late endosomal and lysosomal marker. Panels in
the first column show DIC images. Panels in the fourth column rep-
resent merged images of the second and third columns. Bars=5 μm.
(B) Ratio of colocalization of FGF-1, NGF, BDNF, and NT-3 with
LAMP-2 in the vesicles of alveolar macrophages. The percentages
of double-immunoreactive vesicles to the vesicles immunoreactive
for FGF-1, NGF, BDNF, or NT-3 are shown. (+), the presence of
immunoreactivity; P, probability of significance.Hiruma et al. 136
However, it is true that both humans and mice constitutively
express neurotrophins in alveolar macrophages.
Our previous RT-PCR study has shown that mouse
alveolar macrophages express mRNA for NT-3 but not for
NGF or BDNF [6]. This is not inconsistent with the present
immunocytochemical results showing that NGF, BDNF, and
NT-3 were all expressed in alveolar macrophages but the
ratio of expression was different. Together with our present
and previous results, NT-3-synthesizing macrophages are
more in number than NGF- or BDNF-synthesizing macro-
phages. In addition, as discussed below, the expression of
NGF and BDNF in alveolar macrophages may be attributed
to the uptake from the extracellular milieu rather than
synthesis. The amount of mRNAs for NGF and BDNF was
thus demonstrated to be under detectable levels in our
previous study.
The present colocalization analysis showed that 16%
of FGF-1-expressing macrophages co-expressed NT-3,
whereas only a few FGF-1-expressing macrophages co-
expressed NGF (0.8%) or BDNF (0.3%). Also at the
intracellular level, the frequent colocalization of FGF-1 and
NT-3 in vesicles was observed (89% of FGF-1-IR vesicles
were immunoreactive for NT-3 and 64% of NT-3-IR
vesicles were immunoreactive for FGF-1). Thus, FGF-1
can be stored together with NT-3 in the same vesicles in
macrophages. The colocalization of FGF-1 with neuro-
trophins in the same cell has previously been found in other
samples. Bizon et al. [1] have shown that FGF-1 and NGF
are colocalized in cells of the rat striatum, although it is
unclear whether or not the colocalization is found in
intracellular vesicles.
The present study on the vesicular colocalization
with LAMP-2 and EEA1 indicated that FGF-1 and NT-3
are colocalized with LAMP-2 rather than EEA1, whereas
NGF and BDNF are colocalized with EEA1 rather than
LAMP-2. Thus, it is likely that FGF-1 and NT-3 are
preferentially located in late endosomes or lysosomes,
whereas NGF and BDNF are preferentially located in early
endosomes. Macrophages as well as other immune cells
have lysosomes that function as secretory compartments,
called secretory lysosomes [2]. Different from secretory
granules in general secretory cells, secretory lysosomes
contain not only secretory proteins but also lysosomal
proteins such as LAMP-1, LAMP-2, CD63, and lysosomal
hydrolases [2]. Thus, FGF-1 and NT-3 are possibly located
not only in ordinary lysosomes but also in the secretory
lysosomes. The presence of NGF and BDNF in macro-
phages, both of which tend to be located in early endosomes,
may predominantly result from the uptake (endocytosis)
from the extracellular milieu. In nervous system cells
(neurons and astrocytes), neurotrophins released from their
own or neighboring cells can be endocytosed and then
recycled for exocytosis [13]. Thus, if such a neurotrophin
transport system is also present in macrophages, the source
of NGF and BDNF is most likely to be the alveolar
macrophages themselves in addition to epithelial cells and
fibroblasts. However, direct evidence for uptake, recycling,
and release of FGF-1 and neurotrophins is needed to confirm
this speculation.
In summary, the present study demonstrates that FGF-
1 as well as NT-3 are both substantially expressed in alveolar
Fig. 4. Colocalization of FGF-1, NGF, BDNF, and NT-3 with
EEA1 in vesicles of mouse alveolar macrophages. (A) Confocal
images showing colocalization of FGF-1, NGF, BDNF, and NT-3
with EEA1, a early endosomal marker. Panels in the first column
show DIC images. Panels in the fourth column represent merged
images of the second and third columns. Bars=5 μm. (B) Ratio of
colocalization of FGF-1, NGF, BDNF, and NT-3 with EEA1 in
the vesicles of alveolar macrophages. The percentages of double-
immunoreactive macrophages to the vesicles immunoreactive for
FGF-1 NGF, BDNF, or NT-3 are shown. (+), the presence of
immunoreactivity; P, probability of significance.FGF-1 and NT-3 in Alveolar Macrophages 137
macrophages, and that they are colocalized in the vesicles,
predominantly in late endosomes and lysosomes. The
colocalization of FGF-1 with NT-3 would suggest their
possible coordinated storage, release, and action in alveolar
macrophages.
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